Correlation Between AIM ImmunoTech and Organogenesis Holdings
Can any of the company-specific risk be diversified away by investing in both AIM ImmunoTech and Organogenesis Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AIM ImmunoTech and Organogenesis Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AIM ImmunoTech and Organogenesis Holdings, you can compare the effects of market volatilities on AIM ImmunoTech and Organogenesis Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AIM ImmunoTech with a short position of Organogenesis Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of AIM ImmunoTech and Organogenesis Holdings.
Diversification Opportunities for AIM ImmunoTech and Organogenesis Holdings
-0.58 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between AIM and Organogenesis is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding AIM ImmunoTech and Organogenesis Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Organogenesis Holdings and AIM ImmunoTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AIM ImmunoTech are associated (or correlated) with Organogenesis Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Organogenesis Holdings has no effect on the direction of AIM ImmunoTech i.e., AIM ImmunoTech and Organogenesis Holdings go up and down completely randomly.
Pair Corralation between AIM ImmunoTech and Organogenesis Holdings
Considering the 90-day investment horizon AIM ImmunoTech is expected to under-perform the Organogenesis Holdings. But the stock apears to be less risky and, when comparing its historical volatility, AIM ImmunoTech is 1.53 times less risky than Organogenesis Holdings. The stock trades about -0.22 of its potential returns per unit of risk. The Organogenesis Holdings is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 447.00 in Organogenesis Holdings on August 21, 2025 and sell it today you would earn a total of 66.00 from holding Organogenesis Holdings or generate 14.77% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
AIM ImmunoTech vs. Organogenesis Holdings
Performance |
| Timeline |
| AIM ImmunoTech |
| Organogenesis Holdings |
AIM ImmunoTech and Organogenesis Holdings Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AIM ImmunoTech and Organogenesis Holdings
The main advantage of trading using opposite AIM ImmunoTech and Organogenesis Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AIM ImmunoTech position performs unexpectedly, Organogenesis Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organogenesis Holdings will offset losses from the drop in Organogenesis Holdings' long position.| AIM ImmunoTech vs. Kala Pharmaceuticals | AIM ImmunoTech vs. Oragenics | AIM ImmunoTech vs. Pasithea Therapeutics Corp | AIM ImmunoTech vs. Vyne Therapeutics |
| Organogenesis Holdings vs. SNDL Inc | Organogenesis Holdings vs. Monopar Therapeutics | Organogenesis Holdings vs. Emergent Biosolutions | Organogenesis Holdings vs. Esperion Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |